November 8, 2013—The U.S. Department of Health and Human Services (HHS) has announced $150 million in awards to support 236 new community health center sites in 43 states. … [Read more...]
Drug Companies Have Completed 6 Audits of 340B Providers
A seventh audit is in progress, HRSA reportsNovember 8, 2013—Drug manufacturers have completed six federally authorized audits of 340B covered entities and government officials are following up with the entities involved to determine what comes next. … [Read more...]
HRSA Releases 7 More Findings From 340B Provider Audits
Reports pending for only 2 of the 51 audits conducted in 2012November 5, 2013—The Health Resources and Services Administration (HRSA) has released seven more brief summaries of findings from its audits of 340B covered entities in fiscal year 2012, raising the total to 49 out of 51 audits conducted last year. … [Read more...]
AIDS Group Files Second Suit Alleging 340B Overcharges
Says Johnson & Johnson wrongly denied it up to $2 million in discountsNovember 1, 2013—The AIDS Healthcare Foundation (AHF) has filed suit in California against drug manufacturer Johnson & Johnson (J&J) and its Janssen Therapeutics and Janssen Biotech units to recover as much as $2 million in 340B drug discounts that it claims the family of companies failed to provide it between 2005 and 2012. … [Read more...]
Medicare Outpatient Payment Final Rule Delayed Due to Sequester
In July, CMS proposed continuing ASP plus 6% rate for specified high-cost drugsOctober 31, 2013—Final regulations setting next year's Medicare reimbursement rates for hospital outpatient services and specified high-cost drugs will be held up for about a month due to the recent partial government shutdown. … [Read more...]
Judge Agrees to Speed Up 340B Orphan Drug Lawsuit
All filings in advance of hearing are due by Jan. 17October 31, 2013—A federal district judge has approved the federal government's and drug manufacturers' joint motion to speed up the industry’s lawsuit challenging the legality of the 340B orphan drug exclusion regulation. … [Read more...]
PhRMA and HHS Want to Resolve 340B Orphan Drug Suit Quickly
If judge agrees, ruling on the merits of industry's arguments could come as soon as JanuaryOctober 24, 2013—The federal government and drug manufacturers have agreed to fast-track the industry's lawsuit challenging the legality of the 340B orphan drug exclusion regulation. … [Read more...]